JamesMichaelRossettiDO

PubMed

• Prognostic significance of blast immunophenotype on first post-induction bone marrow biopsy.
  Konstantinos Lontos, Anastasia Tsagianni, Mounzer Agha, Anastasios Raptis, Jing-Zhou Hou, Rafic Farah, Robert L Redner, Annie Im, Kathleen A Dorritie, Alison Sehgal, J...> ;Leukemia & Lymphoma. 2023 Mar 1
• A nomogram using cytogenetics, TP53, and NPM1 mutational status can predict responses to induction chemotherapy in AML.
  Konstantinos Lontos, Anastasia Tsagianni, Mounzer Agha, Anastasios Raptis, Jing-Zhou Hou, Rafic Farah, Robert L Redner, Annie Im, Kathleen A Dorritie, Alison Sehgal, J...> ;Leukemia & Lymphoma. 2022 Dec 1
• 1 citations
  Institution of Standardized Consultation Criteria to Increase Early Palliative Care Utilization in Older Patients With Acute Leukemia.
  Rachel E Rosenblum, Ellen Ormond, Crystal W Smith, Andrew L Bilderback, Stefanie C Altieri Dunn, Dan Buchanan, Emily M Geramita, James M Rossetti, Mamta Bhatnagar, Rob...> ;JCO Oncology Practice. 2023 Feb 1
• 7 citations
  A prospective study of the use of central venous catheters in patients newly diagnosed with acute myeloid leukemia treated with induction chemotherapy.
  Christi McKeown, Asha Ricciuti, Mounzer Agha, Anastasios Raptis, Jing-Zhou Hou, Rafic Farah, Robert L. Redner, Annie Im, Kathleen A. Dorritie, Alison R. Sehgal, James ...> ;Supportive Care in Cancer. 2021 Sep 25
• 3 citations
  Outcomes of Patients With Acute Myeloid Leukemia Who Relapse After 5 Years of Complete Remission.
  Arisha Patel, Mounzer Agha, Anastasios Raptis, Jing-Zhou Hou, Rafic Farah, Robert L. Redner, Annie Im, Kathleen A. Dorritie, Alison R. Sehgal, James M. Rossetti, Melis...> ;Oncology Research. 2021 Sep 7
• 2 citations
  Acute Myeloid Leukemia Presenting as Effusive Constrictive Pericarditis
  Andrew Lutz, Erik B. Schelbert, Konstantinos Lontos, James M. Rossetti, William E. Katz> ;CASE. 2020 Apr 1
• 4 citations
  Paraneoplastic pemphigus as a presentation of acute myeloid leukemia: Early diagnosis and remission
  Salahuddin Siddiqui, Mohammad Bilal, Zachary Otaibi, Farshaad Bilimoria, Nihar Patel, James Rossetti> ;Hematology/oncology and Stem Cell Therapy. 2017 Sep 1
• 1 citations
  Outcomes of patients diagnosed with acute myeloid leukemia after solid organ transplantation
  Konstantinos Lontos, Mounzer Agha, Anastasios Raptis, Jing-Zhou Hou, Rafic Farah, Robert L. Redner, Annie Im, Kathleen A. Dorritie, Alison R. Sehgal, James M. Rossetti...> ;Clinical Transplantation. 2017 Sep 1
• 14 citations
  Efficacy and tolerability of treatment with azacitidine for 5 days in elderly patients with acute myeloid leukemia
  Santhosh Sadashiv, Christie Hilton, Cyrus Khan, James Rossetti, Heather L. Benjamin, Salman Fazal, Entezam A. Sahovic, Richard K. Shadduck, John Lister> ;Cancer Medicine. 2014 Dec 1
• 35 citations
  Azacitidine in the management of patients with myelodysplastic syndromes.
  Cyrus Khan, Neeta Pathe, Salman Fazal, John Lister, James M. Rossetti> ;Therapeutic Advances in Hematology. 2012 Oct 30
• 112 citations
  Activity of azacitidine in chronic myelomonocytic leukemia
  Rubens Costa, Haifaa Abdulhaq, Bushra Haq, Richard K. Shadduck, Joan M. Latsko, Mazen S. Zenati, Folefac Atem, James M. Rossetti, Entezam Sahovic, John Lister> ;Cancer. 2011 Jun 15
• 2 citations
  Viability and potency of hematopoietic progenitor cells after prolonged cryopreservation at -80°C.
  Rubens Costa, Mazen Khattab, Gary L. Gilmore, Entezam Sahovic, Sarah M Miller, James M. Rossetti, Haifaa Abdulhaq, John Lister> ;Acta Haematologica. 2011 May 17
• Activity of azacitidine in chronic myelomonocytic leukemia.
  Costa, R., Abdulhaq, H., Haq, B., Shadduck, R.K., Latsko, J., Zenati, M., Atem, F.D., Rossetti, J.M., Sahovic, E.A., Lister, J.> ;Cancer. 2010-12-23
• 2 citations
  Erythroid variant of chronic myelogenous leukemia
  N Talreja, Haifaa Abdulhaq, Richard K. Shadduck, James M. Rossetti, A Jalil, A Makary, John Lister> ;Leukemia. 2008 Apr 1
• 18 citations
  The role of azacitidine in the treatment of myelodysplastic syndromes.
  Haifaa Abdulhaq, James M. Rossetti> ;Expert Opinion on Investigational Drugs. 2007 Nov 28
• 22 citations
  Recent advances in myelodysplastic syndromes.
  Richard K. Shadduck, Joan M. Latsko, James M. Rossetti, Bushra Haq, Haifaa Abdulhaq> ;Experimental Hematology. 2007 Apr 1
• 13 citations
  Multiple unit HLA-unmatched sex-mismatched umbilical cord blood transplantation for advanced hematological malignancy.
  John Lister, Jeffrey F. Gryn, Karina L. McQueen, David T. Harris, James M. Rossetti, Richard K. Shadduck> ;Stem Cells and Development. 2007 Feb 1
• 67 citations
  Treatment of acute myelogenous leukemia with outpatient azacitidine
  Nimit Sudan, James M. Rossetti, Richard K. Shadduck, Joan M. Latsko, John A. Lech, Robert B. Kaplan, Margaret Kennedy, Jeffrey Gryn, Yacoub Faroun, John Lister> ;Cancer. 2006 Oct 15
• Response and tolerability of a 5-day azacytidine schedule in pateints with myelodysplastic syndromes.
  Haq B, Rossetti JM, Kramer W, Latsko JM, Jasthy S, Lister J, Shadduck RK> ;J. Clin. Oncol.. 2006-06-20
• Response to azacitidine (AZA) in patients with secondary myelodysplastic syndrome.
  Abdulhaq H, Haq B, Rossetti J, Lister J, Shadduck R> ;J. Clin. Oncol.. 2006-06-20
• 4 citations
  Localized lymphoid relapse in the pancreas following allogeneic hematopoietic stem cell transplant for chronic myelogenous leukemia.
  James M. Rossetti, John Lister, Richard K. Shadduck, E. Bloom, S.J. Geyer, Philip F. Caushaj, J. Homann, Pavlos K. Papasavas, M. Cedar> ;Leukemia & Lymphoma. 2003 Jun 1
• Join now to see all